| Autor: |
Khairoun, I., Boltong, M.G., Driessens, F.C.M., Planell, J.A. |
| Zdroj: |
Biomaterials; 1997, Vol. 18 Issue: 23 p1535-1539, 5p |
| Abstrakt: |
Clinical requirements for calcium phosphate bone cements were formulated in terms of the initial setting time, the final setting time, the cohesion time and the ultimate compressive strength. Three cement formulations were tested. The previously developed Biocement H was made of a powder containing α-tertiary calcium phosphate and precipitated hydroxyapatite. Biocement B2 powder was made by adding some CaCO 3 to Biocement H, whereas Biocement B1 was made by adding some CaCO 3 but with simultaneous adjustment of the amount of precipitated hydroxyapatite.The liquid/ powder ratio of the cement paste and the accelerator concentrations (percentage Na 2 HPO 4 ) in cement liquid were varied. For Biocement H there was no combination of L/P ratio and percentage Na 2 HPO 4 for which all clinical requirements were satisfied. However, there was an area of full compliance for Biocements B1 and B2, of which that for B1 was the largest. Therefore, Biocement B1 may be applied in clinical situations as those in orthopaedics, plastic and reconstructive surgery and oral and maxillofacial surgery, even when early contact with blood is inevitable. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect